전남대학교 중앙도서관

METFORMIN, PHENFORMIN AND SORAFENIB AS POTENTIAL THERAPIES FOR HIGH GRADE BRAIN TUMOURS: INVESTIGATING SUPPRESSION OF TUMOUR CELL GROWTH

학술저널

issue: NEURO-ONCOLOGY; NOV 2015, 17 p13-p13, 1p. Supplement: 8
Author: Eagles, L.
Rowther, F.
Tolaymat, I.
Darling, J.
Warr, T.
DB Label: Database : Science Citation Index Expanded

원문보기: Full Text (OUP) Full Text (OUP Near Archive) 등재 - Web of Science 등재 - SCOPUS 조회 - Impact Factor (JCR)

Preparation and Characterisation of Zinc Diethyldithiocarbamate-Cyclodextrin Inclusion Complexes for Potential Lung Cancer Treatment.

학술저널

issue: Pharmaceutics [Pharmaceutics] 2023 Dec 31; Vol. 16 (1). Date of Electronic Publication: 2023 Dec 31.
Author: Kaya A; Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Medicine and Social Care, Medical Technology Research Centre, Anglia Ruskin University, Bishops Hall Lane, Chelmsford CM1 1SQ, UK.
Arafat B; Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Medicine and Social Care, Medical Technology Research Centre, Anglia Ruskin University, Bishops Hall Lane, Chelmsford CM1 1SQ, UK.
Chichger H; Biomedical Research Group, School of Life Sciences, Anglia Ruskin University, Cambridge CB1 1PT, UK.
Tolaymat I; Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Medicine and Social Care, Medical Technology Research Centre, Anglia Ruskin University, Bishops Hall Lane, Chelmsford CM1 1SQ, UK.
Pierscionek B; Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Medicine and Social Care, Medical Technology Research Centre, Anglia Ruskin University, Bishops Hall Lane, Chelmsford CM1 1SQ, UK.
Khoder M; Faculty of Health, Science, Social Care and Education, Kingston University London, Kingston upon Thames KT1 2EE, UK.
Najlah M; Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Medicine and Social Care, Medical Technology Research Centre, Anglia Ruskin University, Bishops Hall Lane, Chelmsford CM1 1SQ, UK.
DB Label: Database : MEDLINE

원문보기: Full Text (원문보기) Full Text (원문보기) Open Access (PubMed Central) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Preparation and Characterization of Disulfiram and Beta Cyclodextrin Inclusion Complexes for Potential Application in the Treatment of SARS-CoV-2 via Nebulization.

학술저널

issue: Molecules (Basel, Switzerland) [Molecules] 2022 Aug 31; Vol. 27 (17). Date of Electronic Publication: 2022 Aug 31.
Author: Pereira AM; Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Bishops Hall Lane, Chelmsford CM1 1SQ, UK.; GMPriority Pharma Ltd., Priors Way, Coggeshall, Colchester CO6 1TW, UK.
Kaya A; Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Bishops Hall Lane, Chelmsford CM1 1SQ, UK.
Alves D; Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Bishops Hall Lane, Chelmsford CM1 1SQ, UK.
Ansari-Fard N; Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Bishops Hall Lane, Chelmsford CM1 1SQ, UK.
Tolaymat I; Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Bishops Hall Lane, Chelmsford CM1 1SQ, UK.
Arafat B; Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Bishops Hall Lane, Chelmsford CM1 1SQ, UK.
Najlah M; Pharmaceutical Research Group, School of Allied Health, Faculty of Health, Education, Medicine and Social Care, Anglia Ruskin University, Bishops Hall Lane, Chelmsford CM1 1SQ, UK.
DB Label: Database : MEDLINE

원문보기: Full Text (원문보기) Full Text (원문보기) Open Access (PubMed Central) 등재 - Web of Science (SCIE) 등재 - SCOPUS 조회 - Impact Factor (JCR)

Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines.

학술저널